Join to view full profile
22 S Greene StMedicine, N3e09Baltimore, MD 21201
Phone+1 410-328-6110
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Vishal Bhatnagar, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2012 - 2015
University of MarylandResidency, Internal Medicine, 2009 - 2012
George Washington University School of Medicine and Health SciencesClass of 2009
Certifications & Licensure
MD State Medical License 2014 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsMost Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes.Erica G Horodniceanu, Tejaswi Datla, Meena N Murugappan, Bindu Kanapuru, Laleh Amiri-Kordestani
Value in Health. 2025-01-01 - 4 citationsFDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, Lisa R Rodriguez, Susan Jin
Clinical Cancer Research. 2024-12-16 - 25 citationsUS Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locall...Asma Dilawari, James Buturla, Christy Osgood, Xin Gao, Wei Chen
Journal of Clinical Oncology. 2024-12-01
Press Mentions
A New FDA Tool Aims to Inform Cancer Care, but Experts Say It Has a Glaring GapJune 30th, 2020
